nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextroamphetamine—SLC18A2—adrenal medulla—adrenal gland cancer	0.363	0.579	CbGeAlD
Dextroamphetamine—SLC6A2—sympathetic nervous system—adrenal gland cancer	0.147	0.235	CbGeAlD
Dextroamphetamine—CYP2D6—urine—adrenal gland cancer	0.0442	0.0705	CbGeAlD
Dextroamphetamine—SLC18A2—adrenal gland—adrenal gland cancer	0.0253	0.0403	CbGeAlD
Dextroamphetamine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—PRKACA—adrenal gland cancer	0.0222	0.0597	CbGpPWpGaD
Dextroamphetamine—SLC6A2—gonad—adrenal gland cancer	0.0177	0.0282	CbGeAlD
Dextroamphetamine—SLC6A2—adrenal gland—adrenal gland cancer	0.0154	0.0246	CbGeAlD
Dextroamphetamine—TAAR1—G alpha (s) signalling events—TSHR—adrenal gland cancer	0.0154	0.0412	CbGpPWpGaD
Dextroamphetamine—ADRA1A—adrenal gland—adrenal gland cancer	0.0144	0.0229	CbGeAlD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0137	0.0368	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.0107	0.0287	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0104	0.028	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00956	0.0257	CbGpPWpGaD
Dextroamphetamine—TAAR1—G alpha (s) signalling events—GNAS—adrenal gland cancer	0.00893	0.024	CbGpPWpGaD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00822	0.0221	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Neuronal System—KCNJ5—adrenal gland cancer	0.00733	0.0197	CbGpPWpGaD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00732	0.0197	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.00628	0.0169	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00626	0.0168	CbGpPWpGaD
Dextroamphetamine—TAAR1—G alpha (s) signalling events—POMC—adrenal gland cancer	0.00602	0.0162	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.0059	0.0158	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Endothelin Pathways—GNAS—adrenal gland cancer	0.00579	0.0155	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Alpha-synuclein signaling—BAD—adrenal gland cancer	0.00574	0.0154	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0057	0.0153	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.00558	0.015	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00558	0.015	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00536	0.0144	CbGpPWpGaD
Dextroamphetamine—ADRA1B—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.00524	0.0141	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.00469	0.0126	CbGpPWpGaD
Dextroamphetamine—ADRA1A—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.00465	0.0125	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Neuronal System—KCNJ5—adrenal gland cancer	0.00437	0.0117	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.00416	0.0112	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00366	0.00984	CbGpPWpGaD
Dextroamphetamine—ADRA1B—G alpha (12/13) signalling events—CDC42—adrenal gland cancer	0.00354	0.0095	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00354	0.00949	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00347	0.00932	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00324	0.00871	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00321	0.00862	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00317	0.0085	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00315	0.00846	CbGpPWpGaD
Dextroamphetamine—ADRA1A—G alpha (12/13) signalling events—CDC42—adrenal gland cancer	0.00314	0.00844	CbGpPWpGaD
Dextroamphetamine—ADRA1B—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.00314	0.00843	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00308	0.00828	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00294	0.0079	CbGpPWpGaD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00287	0.0077	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00286	0.00769	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Neuronal System—PRKACA—adrenal gland cancer	0.00281	0.00754	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00281	0.00754	CbGpPWpGaD
Dextroamphetamine—ADRA1A—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.00279	0.00749	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00277	0.00743	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00264	0.00709	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00249	0.00669	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00241	0.00647	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00235	0.0063	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—POMC—adrenal gland cancer	0.00218	0.00587	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00218	0.00587	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00214	0.00574	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00208	0.00558	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00205	0.00552	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00197	0.0053	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00195	0.00524	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00192	0.00515	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—GNRH1—adrenal gland cancer	0.0019	0.00509	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00185	0.00497	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00185	0.00496	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00183	0.00492	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00174	0.00468	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00173	0.00466	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00173	0.00465	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—TSHR—adrenal gland cancer	0.00169	0.00454	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Neuronal System—PRKACA—adrenal gland cancer	0.00167	0.00449	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—GNAS—adrenal gland cancer	0.00166	0.00447	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00165	0.00442	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—MEN1—adrenal gland cancer	0.00159	0.00427	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00158	0.00425	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Neuronal System—BRAF—adrenal gland cancer	0.00151	0.00406	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00151	0.00405	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00149	0.00401	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00146	0.00393	CbGpPWpGaD
Dextroamphetamine—ADRA1B—LPA receptor mediated events—EGFR—adrenal gland cancer	0.00146	0.00392	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—TSHR—adrenal gland cancer	0.00141	0.00379	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00141	0.00378	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00136	0.00364	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00133	0.00356	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—TSHR—adrenal gland cancer	0.00125	0.00336	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—POMC—adrenal gland cancer	0.00123	0.00331	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00122	0.00329	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PRKACA—adrenal gland cancer	0.00121	0.00326	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0012	0.00323	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.0012	0.00322	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00119	0.00318	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00118	0.00316	CbGpPWpGaD
Dextroamphetamine—ADRA1B—AMPK Signaling—TP53—adrenal gland cancer	0.00115	0.0031	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—POMC—adrenal gland cancer	0.00112	0.00301	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CDC42—adrenal gland cancer	0.00103	0.00276	CbGpPWpGaD
Dextroamphetamine—ADRA1A—AMPK Signaling—TP53—adrenal gland cancer	0.00103	0.00275	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00102	0.00273	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IGF2—adrenal gland cancer	0.000992	0.00266	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—GNAS—adrenal gland cancer	0.000983	0.00264	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000959	0.00258	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Neuronal System—BRAF—adrenal gland cancer	0.000902	0.00242	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.0009	0.00242	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000894	0.0024	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—TERT—adrenal gland cancer	0.000826	0.00222	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000823	0.00221	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—GNAS—adrenal gland cancer	0.000821	0.0022	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000812	0.00218	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000808	0.00217	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GNRHR—adrenal gland cancer	0.000801	0.00215	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000797	0.00214	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000794	0.00213	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000745	0.002	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000729	0.00196	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—GNAS—adrenal gland cancer	0.000729	0.00196	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000726	0.00195	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—TSHR—adrenal gland cancer	0.000724	0.00194	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000721	0.00194	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—BAD—adrenal gland cancer	0.000718	0.00193	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000716	0.00192	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GNRHR—adrenal gland cancer	0.000711	0.00191	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000708	0.0019	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ZNRF3—adrenal gland cancer	0.0007	0.00188	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—POMC—adrenal gland cancer	0.000662	0.00178	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000661	0.00178	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—BRAF—adrenal gland cancer	0.000654	0.00176	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000644	0.00173	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—TSHR—adrenal gland cancer	0.000643	0.00173	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000634	0.0017	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	0.00063	0.00169	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000622	0.00167	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SDHB—adrenal gland cancer	0.000563	0.00151	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000554	0.00149	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—POMC—adrenal gland cancer	0.000552	0.00148	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00052	0.0014	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000492	0.00132	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—POMC—adrenal gland cancer	0.000491	0.00132	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000485	0.0013	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GNRH1—adrenal gland cancer	0.00048	0.00129	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000473	0.00127	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000464	0.00125	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000461	0.00124	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CDC42—adrenal gland cancer	0.000441	0.00118	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SPRY2—adrenal gland cancer	0.000439	0.00118	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000431	0.00116	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TSHR—adrenal gland cancer	0.000428	0.00115	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GNRH1—adrenal gland cancer	0.000426	0.00114	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—GNAS—adrenal gland cancer	0.000421	0.00113	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000412	0.00111	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MEN1—adrenal gland cancer	0.000402	0.00108	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CDC42—adrenal gland cancer	0.000391	0.00105	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SPRY2—adrenal gland cancer	0.00039	0.00105	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TSHR—adrenal gland cancer	0.00038	0.00102	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—EGFR—adrenal gland cancer	0.000374	0.00101	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000374	0.001	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—RRM1—adrenal gland cancer	0.000363	0.000975	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SDHD—adrenal gland cancer	0.000363	0.000975	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MEN1—adrenal gland cancer	0.000357	0.000959	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—TP53—adrenal gland cancer	0.000314	0.000844	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000312	0.000838	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000307	0.000824	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—POMC—adrenal gland cancer	0.000284	0.000761	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000277	0.000745	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000273	0.000732	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—MED12—adrenal gland cancer	0.000271	0.000727	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CDC42—adrenal gland cancer	0.00026	0.000699	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—POMC—adrenal gland cancer	0.000252	0.000676	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IGF2—adrenal gland cancer	0.000251	0.000674	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GNAS—adrenal gland cancer	0.000249	0.000668	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000243	0.000652	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CDC42—adrenal gland cancer	0.000231	0.000621	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IGF2—adrenal gland cancer	0.000223	0.000599	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GNAS—adrenal gland cancer	0.000221	0.000593	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000215	0.000579	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TERT—adrenal gland cancer	0.000209	0.000561	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	0.000197	0.00053	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TERT—adrenal gland cancer	0.000186	0.000498	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—BAD—adrenal gland cancer	0.000182	0.000488	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—POMC—adrenal gland cancer	0.000167	0.00045	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—BRAF—adrenal gland cancer	0.000165	0.000444	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—BAD—adrenal gland cancer	0.000161	0.000433	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—EGFR—adrenal gland cancer	0.00016	0.000431	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GNAS—adrenal gland cancer	0.00016	0.00043	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	0.000157	0.000422	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—POMC—adrenal gland cancer	0.000149	0.0004	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—BRAF—adrenal gland cancer	0.000147	0.000395	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000142	0.000382	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00012	0.000321	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—POMC—adrenal gland cancer	0.000108	0.000289	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000106	0.000285	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—EGFR—adrenal gland cancer	9.47e-05	0.000254	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	8.59e-05	0.000231	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—EGFR—adrenal gland cancer	8.41e-05	0.000226	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TP53—adrenal gland cancer	7.95e-05	0.000214	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TP53—adrenal gland cancer	7.06e-05	0.00019	CbGpPWpGaD
